Antibiotic can be used to treat lethal breast cancer

The breast cancer triple negative is the type of cancer more deadly, accounting for half of the deaths attributed to the disease, in which the majority are young women.

This type of cancer is the most aggressive because it has the greatest chance of metastasis, that is, of spreading to other parts of the body besides the part already affected.

Some molecular elements (oncogenes) contaminate good cells and transform them into “bad” cells. The biggest challenge is to fight these cancer cells without harming healthy ones.

And that is exactly what a survey did. The researchers found that clofazimine (antibiotic) can stop the progression of triple breast cancer .

Clofazimine is most effective if used in conjunction with doxorubicin .

While the first drug prevents the reproduction of cancer cells, the second chemical inhibits their growth.

Produced on all continents, this substance is easy to find and is an essential medicine, according to the World Health Organization (WHO).

Until then, this disease did not respond to any type of treatment. With the new discovery, new ways to fight triple negative breast cancer may be developed in the future.

This discovery was made in vitro . The next step, the scientists say, is to run new tests on volunteer patients.

The study was done at the University of Geneva, Switzerland and published in the journal Cancer Letters.

Read more: Breast cancer metastasis: the light may be to blame

Triple negative breast cancer

Triple negative breast cancer, like other types, can be triggered by a number of factors, including: sex (being a woman), age (being over 45), family history, obesity and smoking .

The disease gets its name because it is not classified into any of the three common breast cancer biotypes (estrogen receptor, progesterone receptor and HER-2 protein).

The diagnosis is made by a mammography exam . The earlier it is discovered and treated, the greater the chances of a cure. If in doubt, seek a gynecologist.

Triple negative breast cancer was fought by an easily accessible antibiotic in an in vitro test (laboratory). Other tests, especially in humans, must be done before this drug is prescribed as a form of treatment.

Even so, this is yet another example of how science has been evolving to fight various types of cancer.